Published in

Springer Nature [academic journals on nature.com], Leukemia, 6(31), p. 1446-1449, 2017

DOI: 10.1038/leu.2017.58

Links

Tools

Export citation

Search in Google Scholar

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO